Author:
Ziegler S.,Nadal D.,Kreth H. W.,Schrod L.,Schöni M. H.,Wahn V.,Horneff G.,Holländer G. A.,Heinigner U.,Urbanek R.,Schuster A.,Götz M.,Birrer P.,Wildhaber J. H.,Oberwaldner B.,Bauer C.-P.,Innenmoser J.,Gruber W.,Nicolai T.,Eber E.,Hartmann H.,Fanconi S.,Burger R.,Kachel W.,Schaible T.,Paul K.,Hetzer R.
Publisher
Springer Berlin Heidelberg
Reference198 articles.
1. Hoibi N, Ciofu O, Jensen T et al. (1996) Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis. Pediatr Infect Dis J 15:738–743
2. Jacobs RF, Schutze GE, Young RA et al. (1997) Antimicrobial agents. In: Long SS, Pickering LK, Prober CG (eds) Practice and principles of pediatric infectious diseases. Churchill Livingstone, New York, pp 1606–1662
3. Lebel MH, McCracken GH jr (1988) Aztreonam: Review of the clinical experience and potential uses in pediatrics. Pediatr Infect Dis J 7:331
4. Mims CA, Playfair JHL, Roitt IM et al. (1993) Medical microbiology. Mos-by, St. Louis, pp 35.1–35.22
5. Nelson JD (1996) Pocket book of pediatric antimicrobial therapy. Williams & Wilkins, Baltimore